Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia-Reference-Cited by-同舟云学术

Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia

Published:2020-12-18 Issue:4 Volume:22 Page:483-495
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ferrari Filipe¹^ORCID,Martins Vítor M.²,Rocha Viviane Z.³,Santos Raul D.³⁴

Affiliation:

1. Postgraduate Program in Cardiology and Cardiovascular Sciences, Hospital De Clínicas De Porto Alegre, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil

2. Graduate Program in Cardiology and Cardiovascular Sciences, School of Medicine, Hospital De Clínicas De Porto Alegre, Porto Alegre, Brazil

3. Lipid Clinic Heart Institute (Incor), University of São Paulo Medical School Hospital, São Paulo, Brazil

4. Academic Research Organisation, Hospital Israelita Albert Einstein, São Paulo, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1832991

Reference78 articles.

1. Familial hypercholesterolaemia

2. Clinical Genetic Testing for Familial Hypercholesterolemia

3. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

4. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

5. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MODERN VIEWS ON THE PATHOGENESIS OF IMMUNE DYSFUNCTION AGAINST THE BACKGROUND OF THE METABOLIC SYNDROME IN ISCHEMIC HEART DISEASE;Ukrainian Journal of Laboratory Medicine;2023-12-30

2. Improving pediatric familial hypercholesterolemia diagnosis by looking deeper into families;Atherosclerosis;2023-11

3. Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment;European Journal of Preventive Cardiology;2023-10-19

4. Fixed triple combination of amlodipine, perindopril and atorvastatin in the focus of cardiovascular effectiveness and safety;Eurasian heart journal;2023-10-10

5. Updates in the management of pediatric dyslipidemia;Current Opinion in Lipidology;2023-03-17